 | Up a level |
Koelzer, V H; Glatz, K; Bubendorf, L; Weber, A; Gaspert, A; Cathomas, G; Lugli, Alessandro; Zippelius, A; Kempf, W; Mertz, K D (2017). [The pathology of adverse events with immune checkpoint inhibitors]. Der Pathologe, 38(3), pp. 197-208. Springer 10.1007/s00292-017-0281-1
Mertz, K D; Schmid, M; Burger, B; Itin, P; Palmedo, G; Schärer, L; Kutzner, H; Fernández Figueras, M T; Cribier, B; Pfaltz, M; Kempf, W (2011). Detection of Merkel cell polyomavirus in epidermodysplasia-verruciformis-associated skin neoplasms. Dermatology, 222(1), pp. 87-92. Basel: Karger 10.1159/000321880
Lapointe, A-K; Hofbauer, G; Anliker, M; Arnold, A; Binet, I; Hunger, R; Kempf, W; Pascual, M; Pelloni, F; Serra, A; Laffitte, E (2010). [Swiss clinical practice guidelines for skin cancer in organ transplant recipients]. Revue médicale suisse, 6(246), pp. 854-9. Genève: Médecine & Hygiène
Kempf, W; Meylan, P; Gerber, S; Aebi, C; Agosti, R; Büchner, S; Coradi, B; Garweg, J; Hirsch, Hh; Kind, C; Lauper, U; Lautenschlager, S; Reusser, P; Ruef, C; Wunderli, W; Nadal, D (2007). Swiss recommendations for the management of varicella zoster virus infections. Swiss medical weekly, 137(17-18), pp. 239-51. Muttenz: EMH Schweizerischer Ärzteverlag
